TY - JOUR
T1 - Molecular beacon-enabled purification of living cells by targeting cell type-specific mRNAs
AU - Wile, Brian M.
AU - Ban, Kiwon
AU - Yoon, Young Sup
AU - Bao, Gang
PY - 2014/1/1
Y1 - 2014/1/1
N2 - Molecular beacons (MBs) are dual-labeled oligonucleotides that fluoresce only in the presence of complementary mRNA. The use of MBs to target specific mRNAs allows sorting of specific cells from a mixed cell population. In contrast to existing approaches that are limited by available surface markers or selectable metabolic characteristics, the MB-based method enables the isolation of a wide variety of cells. For example, the ability to purify specific cell types derived from pluripotent stem cells (PSCs) is important for basic research and therapeutics. In addition to providing a general protocol for MB design, validation and nucleofection into cells, we describe how to isolate a specific cell population from differentiating PSCs. By using this protocol, we have successfully isolated cardiomyocytes differentiated from mouse or human PSCs (hPSCs) with 1/497% purity, as confirmed by electrophysiology and immunocytochemistry. After designing MBs, their ordering and validation requires 2 weeks, and the isolation process requires 3 h.
AB - Molecular beacons (MBs) are dual-labeled oligonucleotides that fluoresce only in the presence of complementary mRNA. The use of MBs to target specific mRNAs allows sorting of specific cells from a mixed cell population. In contrast to existing approaches that are limited by available surface markers or selectable metabolic characteristics, the MB-based method enables the isolation of a wide variety of cells. For example, the ability to purify specific cell types derived from pluripotent stem cells (PSCs) is important for basic research and therapeutics. In addition to providing a general protocol for MB design, validation and nucleofection into cells, we describe how to isolate a specific cell population from differentiating PSCs. By using this protocol, we have successfully isolated cardiomyocytes differentiated from mouse or human PSCs (hPSCs) with 1/497% purity, as confirmed by electrophysiology and immunocytochemistry. After designing MBs, their ordering and validation requires 2 weeks, and the isolation process requires 3 h.
UR - http://www.scopus.com/inward/record.url?scp=84961290142&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84961290142&partnerID=8YFLogxK
U2 - 10.1038/nprot.2014.154
DO - 10.1038/nprot.2014.154
M3 - Article
C2 - 25232937
AN - SCOPUS:84961290142
SN - 1754-2189
VL - 9
SP - 2411
EP - 2424
JO - Nature Protocols
JF - Nature Protocols
IS - 10
ER -